The nation of Zimbabwe has declined a significant US health deal worth 367 million US dollars (272 million pounds) over five years over Washington's demand for confidential information.
This rejection came to light following a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
A government representative later stated that the United States was demanding access to health data for scientific study and profit but was not willing to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged continued talks to find a deal suitable to both sides so the country's critical HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court blocked a similar health funding agreement after concerns were filed about the security of citizens' health data.
After returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and responsibility.
According to statements, Sixteen African countries have to date agreed to similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research without any certainty that the final treatments would be available to our people should a new pandemic arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems already established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is intended to ensure that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future collaboration could be designed in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but recommended that negotiations need to persist since much of the country's HIV programmes depended on international support.
"In cases where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it commented.
The situation underscores the ongoing challenges between accepting crucial foreign assistance and protecting national sovereignty in an ever more data-driven world.